Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Incyte Corporation
Incyte Corporation
Children's Oncology Group
Eastern Cooperative Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
Novartis
Korean Society of Hematology
Enliven Therapeutics
Novartis
City of Hope Medical Center
Shenzhen TargetRx Co., Ltd.
Augusta University
Takeda
University of California, Irvine
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Centre Hospitalier Henri Duffaut - Avignon
M.D. Anderson Cancer Center
Novartis
City of Hope Medical Center
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Terns, Inc.
SWOG Cancer Research Network
City of Hope Medical Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Novartis
Novartis
Children's Oncology Group
OHSU Knight Cancer Institute
City of Hope Medical Center
Medical College of Wisconsin
Novartis
Barbara Ann Karmanos Cancer Institute
Gruppo Italiano Malattie EMatologiche dell'Adulto
Roswell Park Cancer Institute
Enliven Therapeutics
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
University of Pisa
Ascentage Pharma Group Inc.
Thomas Jefferson University
Medical College of Wisconsin
Fred Hutchinson Cancer Center
City of Hope Medical Center
Ascentage Pharma Group Inc.
Fundacion CRIS de Investigación para Vencer el Cáncer
Masaryk University
Il-Yang Pharm. Co., Ltd.
Il-Yang Pharm. Co., Ltd.